Pediatric drug development in China: Reforms and challenges.

Area of Science:

• Pediatric pharmacology
• Pharmaceutical policy
• Regulatory science

Background:

• Child and adolescent pediatricians in China encounter difficulties in prescribing appropriate medications for pediatric patients.
• The Chinese government has implemented policies over the past eight years to encourage the development of age-appropriate pediatric medicines.

Purpose of the Study:

• To introduce the current status of pediatric drugs in China.
• To identify obstacles hindering pediatric drug development.
• To review regulatory reforms related to pediatric medicines in China.

Main Methods:

• Review of current pediatric drug landscape in China.
• Analysis of challenges in pediatric drug development.
• Examination of regulatory policies and reforms.

Main Results:

• Common issues include insufficient drug label information for children, inadequate age-appropriate dosage forms and strengths, and a general shortage of pediatric drugs.
• There are neither mandatory requirements nor sufficient financial incentives for the development of pediatric medicines.
• Progress has been made in pediatric drug development and distribution, but availability remains a concern.

Conclusions:

• Despite recent government initiatives, significant challenges persist in the development and availability of pediatric medications in China.
• Further efforts are crucial to enhance the availability of age-appropriate drugs for children.
• Addressing the identified obstacles is necessary to improve pediatric pharmacotherapy in China.